Discover life science companies across the East of England, including biotechnology firms, CROs, research organisations and innovation hubs.
Microscopy and imaging systems for developmental and cardiovascular research
Indigo Scientific is a UK manufacturer and supplier of optical and microscopy imaging systems for life science research. The company's High-Resolution Episcopic Microscopy systems generate detailed 3D reconstructions of biological samples such as mouse embryos and hearts through serial block-face imaging, widely used…
LNP-mRNA growth factor therapy to restore hearing loss
CamGene Therapeutics is a preclinical biotechnology company developing lipid nanoparticle-delivered mRNA medicines to treat hearing loss at its underlying cellular cause. Its lead approach uses an LNP-mRNA growth factor therapeutic designed to regenerate cochlear nerve cells and reduce inflammation, aiming to restore…
Contract microscopy imaging and analysis services for life sciences
Nikon BioImaging Lab is a contract research organisation based at the Babraham Research Campus in Cambridge, providing microscope-based imaging and analysis services to biotech and pharmaceutical clients. Services span sample imaging, high-content acquisition, AI-powered data analysis using Nikon's NIS Elements…
Preclinical DMPK, bioanalysis and toxicology CRO
Pharmidex is a UK contract research organisation providing preclinical drug discovery and development services across DMPK, bioanalysis, toxicology, histology and in vitro ADME. Operating under GLP and GCP accreditation from its Hatfield facility, the company supports programmes in oncology, CNS, respiratory and…
UK life sciences research campus and innovation cluster
Norwich Research Park is a leading UK life science research park, home to the Earlham Institute, Quadram Institute, John Innes Centre and The Sainsbury Laboratory, alongside the University of East Anglia. Norwich Research Park is the only site in the UK to host three BBSRC-funded research institutes, making it a…
Gene therapy immune regulators for infection, cancer and autoimmunity
Virothera develops gene therapies intended to regulate immune responses in persistent diseases. Its approach draws on human versions of immune-modifying proteins that viruses have evolved to influence immune cells. The company aims to use these proteins to create targeted treatments with potential advantages over some…
Plasma fractionation and manufacture of plasma-derived therapies
Kedrion Biopharma is a biopharmaceutical manufacturer specialising in the fractionation of human blood plasma to produce albumin solutions, immunoglobulins and coagulation factors for the treatment of rare and life-threatening conditions including immunodeficiencies and bleeding disorders. Operating from a 130,000…
Molecular disease research spanning genetics, neurobiology and intracellular infections
Cambridge Institute for Medical Research is a University of Cambridge institute studying the molecular mechanisms of human disease. Researchers investigate protein folding, cellular quality control, membrane trafficking and organelle function, focusing on rare genetic disorders, neurological conditions and…
Single-cell sequencing kits, instruments and genomic analysis services
Singleron Biotechnologies is a life science tools company providing single-cell sequencing technologies and genomic analysis services. Its portfolio includes microfluidic sample-processing kits, instruments, library preparation reagents and bioinformatics software for studying gene expression and molecular features in…
Collagen-based biomaterials as sustainable alternatives to leather
PACT Earth is a UK biotechnology company developing collagen-based biomaterials for the fashion and textiles industries. Its flagship material is produced from ethically sourced collagen derived from freshwater fish farming by-products, processed without synthetic plastics or harsh chemicals. PACT targets brand…
Single-cell genomics and AI platform for autoimmune and fibrotic disease
Ensocell is a Cambridge-based biotechnology company developing precision biologics for autoimmune, inflammatory, and fibrotic diseases. Its platform integrates single-cell and spatial genomics with AI-based computational tools and advanced cell models to identify novel disease intervention points and design targeted…
RNA immunotherapies targeting novel tumour-specific antigens
Epitopea is a biopharma company developing off-the-shelf RNA-based immunotherapies for hard-to-treat cancers. Using spatial immunopeptidomics, genomics, and systems bioinformatics, the company identifies aberrantly-expressed tumour-specific antigens that are broadly shared across patients with the same tumour type.…
Agricultural technology membership network
Agri-TechE is an independent, not-for-profit membership organisation, headquartered in Cambridge and operating without government funding. It connects farmers, researchers, technologists, entrepreneurs and agribusinesses through events, site visits, funding support and collaborative projects, with its flagship annual…
Life science campus co-locating early-stage companies with discovery research
Babraham Research Campus is a 430-acre life science campus south of Cambridge, home to over 60 companies and 300 academic researchers from the Babraham Institute. Campus companies have access to nine open-access scientific facilities operated by the Babraham Institute, including flow cytometry, genomics sequencing,…
Mechanobiology platform for target discovery and validation
Mechanome Bio is a Cambridge-based company developing a mechano-transcriptomics platform for biomarker and drug target discovery. The platform combines spatial multi-omics data from human tissue samples with mechanical tissue profiling and in silico tissue modelling to identify targets linked to changes in tissue…
Computationally designed broadly protective vaccines against pandemic viruses
DIOSynVax is a clinical-stage biotechnology company developing broadly protective vaccines using a computational antigen design platform. The company's technology applies protein structure modelling and immune optimisation to engineer synthetic vaccine antigen payloads targeting conserved regions of viruses, enabling…
Contract computational chemistry and molecular design services
CompChem Solutions is a Cambridge-based computational chemistry consultancy supporting pharmaceutical, biotechnology and academic drug discovery programmes. Its services include molecular modelling, virtual screening, chemical library design, cheminformatics, property prediction and hit-to-lead optimisation. Founded…
AI-enabled personalised dosing for drug-digital combination therapies
Closed Loop Medicine develops combination products integrating pharmaceutical therapies with AI-powered digital companions to personalise drug dosing for chronic conditions. Its platform applies pharmacometric modelling and patient response data to optimise treatment regimens. The pipeline includes co-packaged drug…
Industrial fermentation and yeast technology solutions
AB Biotek is an industrial biotechnology company developing yeast strains and fermentation technologies for the global food, beverage, bioethanol and animal nutrition sectors. The company provides microbial ingredients and process optimisation solutions that support the production of wine, beer, spirits, fuel ethanol…
Genome-editing platform mapping cancer drug resistance and druggable vulnerabilities
BASE Rx is a Wellcome Sanger Institute spin-out applying genome-editing and DNA sequencing technologies to cancer drug discovery. The company maps single-base genetic variants to identify druggable vulnerabilities in cancer genes and predict the DNA changes that drive resistance to cancer therapies. BASE Rx aims to…